Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial
Top Cited Papers
- 1 September 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 364 (9440), 1127-1134
- https://doi.org/10.1016/s0140-6736(04)17098-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Gastrointestinal stromal tumors–a reviewActa Orthopaedica, 2004
- Management of malignant gastrointestinal stromal tumoursThe Lancet Oncology, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Diagnosis of gastrointestinal stromal tumors: A consensus approachHuman Pathology, 2002
- Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A reviewHuman Pathology, 2002
- The histopathological differential diagnosis of gastrointestinal stromal tumoursJournal of Clinical Pathology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- A stagewise rejective multiple test procedure based on a modified Bonferroni testBiometrika, 1988